Cohu Reports Third Quarter 2018 Results
Management believes the presentation of these non-GAAP financial
measures, when taken together with the corresponding GAAP financial
measures, provides meaningful supplemental information regarding the
Company's operating performance. Our management uses these non-GAAP
financial measures in assessing the Company's operating results, as well
as when planning, forecasting and analyzing future periods and these
non-GAAP measures allow investors to evaluate the Company’s financial
performance using some of the same measures as management. Management
views share-based compensation as an expense that is unrelated to the
Company’s operational performance as it does not require cash payments
and can vary in amount from period to period and the elimination of
amortization charges provides better comparability of pre and
post-acquisition operating results and to results of businesses
utilizing internally developed intangible assets. Management initiated
certain restructuring activities including employee headcount reductions
and other organizational changes to align our business strategies in
anticipation of the completion of the merger with Xcerra. Restructuring
costs have been excluded because such expense is not used by Management
to assess the core profitability of Cohu’s business operations.
Manufacturing transition costs relate principally to employee severance
expenses incurred as a result of moving certain manufacturing activities
to Asia as part of our ongoing cost reduction efforts and employee
severance are costs incurred in conjunction with the termination of
certain employees to streamline our operations and reduce costs.
Management has excluded these costs primarily because they are not
reflective of the ongoing operating results and they are not used to
assess ongoing operational performance. Acquisition costs, fair value
adjustment to contingent consideration and inventory step-up costs have
been excluded by management as they are unrelated to the core operating
activities of the Company and the frequency and variability in the
nature of the charges can vary significantly from period to period.
Excluding this data provides investors with a basis to compare Cohu’s
performance against the performance of other companies without this
variability. However, the non-GAAP financial measures should not be
regarded as a replacement for (or superior to) corresponding, similarly
captioned, GAAP measures. The presentation of non-GAAP financial
measures above may not be comparable to similarly titled measures
reported by other companies and investors should be careful when
comparing our non-GAAP financial measures to those of other companies.
(a)
|
|
|
|
7.9%, 13.8% and 11.1% of net sales, respectively.
|
(b)
|
|
|
|
To eliminate compensation expense for employee stock options, stock
units and our employee stock purchase plan.
|
(c)
|
|
|
|
To eliminate the amortization of acquired intangible assets.
|
(d)
|
|
|
|
To eliminate restructuring costs incurred during third quarter of
2018 in anticipation of the closing of the Xcerra acquisition.
|
(e)
|
|
|
|
To eliminate manufacturing transition costs.
|
(f)
|
|
|
|
To eliminate fair value adjustment to contingent consideration
related to the acquisition of Kita.
|
(g)
|
|
|
|
To eliminate professional fees and other direct incremental expenses
incurred related to acquisitions.
|
(h)
|
|
|
|
To eliminate the inventory step-up costs incurred related to the
acquisition of Kita.
|
(i)
|
|
|
|
13.2%, 21.3% and 15.7% of net sales, respectively.
|
(j)
|
|
|
|
To adjust the provision for income taxes related to the adjustments
described above based on applicable tax rates.
|
(k)
|
|
|
|
All periods presented were computed using the number of GAAP diluted
shares outstanding.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COHU, INC.
|
Supplemental Reconciliation of GAAP Results to Non-GAAP Financial
Measures (Unaudited) *
|
(in thousands, except per share amounts)
|
|
|
|
|
Nine Months Ended
|
|
|
|
|
September 29,
|
|
|
September 30,
|
|
|
|
|
2018
|
|
|
2017
|
Income from operations - GAAP basis (a)
|
|
|
|
$
|
30,590
|
|
|
|
$
|
30,082
|
|
Non-GAAP adjustments:
|
|
|
|
|
|
|
|
Share-based compensation included in (b):
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
|
|
408
|
|
|
|
|
327
|
|
Research and development
|
|
|
|
|
1,098
|
|
|
|
|
856
|
|
SG&A
|
|
|
|
|
3,991
|
|
|
|
|
4,153
|
|
|
|
|
|
|
5,497
|
|
|
|
|
5,336
|
|
Amortization of intangible assets included in (c):
|
|
|
|
|
|
|
|
Cost of sales
|
|
|
|
|
1,959
|
|
|
|
|
2,015
|
|
SG&A
|
|
|
|
|
1,158
|
|
|
|
|
1,149
|
|
|
|
|
|
|
3,117
|
|
|
|
|
3,164
|
|
Restructuring costs included in (d):
|
|
|
|
|
|
|
|
Research and development
|
|
|
|
|
273
|
|
|
|
|
-
|
|
SG&A
|
|
|
|
|
107
|
|
|
|
|
-
|
|
|
|
|
|
|
380
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
Manufacturing transition and severance costs included in SG&A (e)
|
|
|
|
|
110
|
|
|
|
|
452
|
|
|
|
|
|
|
|
|
|
Adjustment to contingent consideration included in SG&A (f)
|
|
|
|
|
657
|
|
|
|
|
668
|
|
|
|
|
|
|
|
|
|
Acquisition costs included in SG&A (g)
|
|
|
|
|
5,178
|
|
|
|
|
328
|
|
|
|
|
|
|
|
|
|
Inventory step-up included in cost of sales (h)
|
|
|
|
|
-
|
|
|
|
|
1,404
|
|
|
|
|
|
|
|
|
|
Income from operations - non-GAAP basis (i)
|
|
|
|
$
|
45,529
|
|
|
|
$
|
41,434
|
|
|
|
|
|
|
|
|
|
Income from continuing operations - GAAP basis
|
|
|
|
$
|
24,573
|
|
|
|
$
|
26,226
|
|
Non-GAAP adjustments (as scheduled above)
|
|
|
|
|
14,939
|
|
|
|
|
11,352
|
|
Tax effect of non-GAAP adjustments (j)
|
|
|
|
|
(1,179
|
)
|
|
|
|
(1,316
|
)
|
Income from continuing operations - non-GAAP basis
|
|
|
|
$
|
38,333
|
|
|
|
$
|
36,262
|
|
|
|
|
|
|
|
|
|
GAAP income per share - diluted
|
|
|
|
$
|
0.83
|
|
|
|
$
|
0.92
|
|
|
|
|
|
|
|
|
|
Non-GAAP income per share - diluted (k)
|
|
|
|
$
|
1.29
|
|
|
|
$
|
1.27
|
|
|
|
|
|
|
|
|
|
Gross Profit Reconciliation
|
|
|
|
|
|
|
|
Gross profit - GAAP basis
|
|
|
|
$
|
115,430
|
|
|
|
$
|
106,295
|
|
Non-GAAP adjustments to cost of sales (as scheduled above)
|
|
|
|
|
2,367
|
|
|
|
|
3,746
|
|
Gross profit - Non-GAAP basis
|
|
|
|
$
|
117,797
|
|
|
|
$
|
110,041
|
|
Non-GAAP gross profit as a percentage of net sales
|
|
|
|
|
41.9
|
%
|
|
|
|
41.0
|
%
|
|
|
|
|
|
|
|
|
Adjusted EBITDA Reconciliation
|
|
|
|
|
|
|
|
Net income - GAAP basis
|
|
|
|
$
|
24,573
|
|
|
|
$
|
25,948
|
|
Loss from discontinued operations
|
|
|
|
|
-
|
|
|
|
|
278
|
|
Income tax provision
|
|
|
|
|
6,897
|
|
|
|
|
4,273
|
|
Interest and other, net
|
|
|
|
|
(880
|
)
|
|
|
|
(417
|
)
|
Amortizaton
|
|
|
|
|
3,117
|
|
|
|
|
3,164
|
|
Depreciation
|
|
|
|
|
4,159
|
|
|
|
|
3,567
|
|
Other non-GAAP adjustments (as scheduled above)
|
|
|
|
|
11,822
|
|
|
|
|
8,188
|
|
Adjusted EBITDA
|
|
|
|
$
|
49,688
|
|
|
|
$
|
45,001
|
|
Adjusted EBITDA as a percentage of net sales
|
|
|
|
|
17.7
|
%
|
|
|
|
16.8
|
%
|
|
|
|
|
|
|
|
|
Operating Expense Reconciliation
|
|
|
|
|
|
|
|
Operating Expense - GAAP basis
|
|
|
|
$
|
84,840
|
|
|
|
$
|
76,213
|
|
Non-GAAP adjustments to R&D and SG&A (as scheduled above)
|
|
|
|
|
(12,572
|
)
|
|
|
|
(7,606
|
)
|
Operating Expenses - Non-GAAP basis
|
|
|
|
$
|
72,268
|
|
|
|
$
|
68,607
|
|
|
|
|
|
|
|
|
|
* Excludes operating results from Xcerra acquired on October 1, 2018
|
|